These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1085134)

  • 1. Relationship of phytohaemagglutinin-induced lymphocyte transformation to disease activity in systemic lupus erythematosus.
    Hughes P; Holt S; Rowell NR; Dodd JK
    Ann Rheum Dis; 1976 Apr; 35(2):97-105. PubMed ID: 1085134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
    Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
    Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus.
    Foad B; Adams LE; Litwin A; Hess EV
    Ann Rheum Dis; 1975 Oct; 35(5):407-14. PubMed ID: 1234408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of T-lymphocytes in systemic lupus erythematosus.
    Whittingham S; Rodger B; Matthews JV; Mackay IR
    Clin Exp Immunol; 1978 Oct; 34(1):63-8. PubMed ID: 312168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.
    Hughes P; Holt S; Rowell NR; Allonby ID; Janis K; Dodd JK
    Clin Exp Immunol; 1977 May; 28(2):233-40. PubMed ID: 301448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.
    Landry M
    Arch Dermatol; 1977 Feb; 113(2):147-54. PubMed ID: 300001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.
    Horwitz DA; Garrett MA
    Clin Exp Immunol; 1977 Jan; 27(1):92-9. PubMed ID: 300308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of treatment with encorton and cytostatics on cellular immunity in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1982; 20(3-4):137-42. PubMed ID: 7187069
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient.
    Glinski W; Gershwin ME; Budman DR; Steinberg AD
    Clin Exp Immunol; 1976 Nov; 26(2):228-38. PubMed ID: 1086753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed in vitro B-lymphocyte differentiation in systemic lupus erythematosus.
    Bobrove AM; Miller P
    Arthritis Rheum; 1977; 20(7):1326-33. PubMed ID: 303104
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients.
    Paty JG; Sienknecht CW; Townes AS; Hanissian AS; Miller JB; Masi AT
    Am J Med; 1975 Dec; 59(6):769-79. PubMed ID: 1190253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
    Lavalle C; Alcocer J; Gudiño J; Fraga A
    Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoallergic states. Tumor immunology. Impaired function of peripheral lymphocytes in systemic lupus erythematosus.
    Malavé I; Cuadra C
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):412-9. PubMed ID: 591106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-lymphocyte subpopulation in untreated SLE. Variations with disease activity.
    Rivero SJ; Llorente L; Díaz-Jouanen E; Alarcón-Segovia D
    Arthritis Rheum; 1977; 20(6):1169-73. PubMed ID: 332183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.